Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Analgesic Response to Ibuprofen
NCT03893175Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- May 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acute pain comparing Ibuprofen with Placebo (2 arms). Primary endpoint: Analgesic response up to 7 days. Started May 2019; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03893175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893175.